VCL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.07509573360676E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29509958313179E-10 |
Normal-vs-Stage2 |
1.87594384470913E-12 |
Normal-vs-Stage3 |
1.16040510533821E-11 |
Normal-vs-Stage4 |
2.76401124210679E-12 |
Stage1-vs-Stage2 |
1.103910E-02 |
Stage1-vs-Stage3 |
2.173800E-01 |
Stage1-vs-Stage4 |
2.681700E-02 |
Stage2-vs-Stage3 |
1.204640E-01 |
Stage2-vs-Stage4 |
5.823800E-01 |
Stage3-vs-Stage4 |
2.938000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.3868910160636E-12 |
Normal-vs-AfricanAmerican |
5.02429986504183E-10 |
Normal-vs-Asian |
4.262200E-02 |
Caucasian-vs-AfricanAmerican |
2.144600E-01 |
Caucasian-vs-Asian |
3.643400E-01 |
AfricanAmerican-vs-Asian |
2.566400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.48412401759879E-12 |
Normal-vs-Female |
1.41849976209585E-10 |
Male-vs-Female |
7.065800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.338090E-03 |
Normal-vs-Age(41-60Yrs) |
2.4366952899868E-11 |
Normal-vs-Age(61-80Yrs) |
2.81008549762873E-12 |
Normal-vs-Age(81-100Yrs) |
1.25110000026574E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.272200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.712000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.010400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.289800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.968400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.600570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.183800E-02 |
Normal-vs-Grade 2 |
4.58849958029361E-10 |
Normal-vs-Grade 3 |
1.2134737659153E-13 |
Normal-vs-Grade 4 |
5.58497692537685E-12 |
Grade 1-vs-Grade 2 |
2.084200E-01 |
Grade 1-vs-Grade 3 |
1.375530E-02 |
Grade 1-vs-Grade 4 |
2.408000E-02 |
Grade 2-vs-Grade 3 |
1.857730E-03 |
Grade 2-vs-Grade 4 |
3.650300E-02 |
Grade 3-vs-Grade 4 |
8.872200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.65329980209117E-11 |
Normal-vs-ccB subtype |
3.0991997856944E-10 |
ccA subtype-vs-ccB subtype |
6.459200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.98523444747434E-12 |
Normal-vs-N1 |
3.042400E-04 |
N0-vs-N1 |
9.828000E-01 |
|
|